Serum stratifin measurement is useful for evaluating disease severity and outcomes in patients with acute exacerbation of interstitial lung disease: a retrospective study

Abstract Background Serum levels of stratifin (SFN), a member of the 14-3-3 protein family, increase in patients with drug-induced lung injury associated with diffuse alveolar damage. Therefore, we hypothesised that SFN levels would be higher in those experiencing acute exacerbation of interstitial...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Noriko Sakuma, Mitsuhiro Abe, Daisuke Ishii, Takeshi Kawasaki, Noriaki Arakawa, Shinichiro Matsuyama, Yoshiro Saito, Takuji Suzuki, Koichiro Tatsumi
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2024-07-01
coleção:	BMC Pulmonary Medicine
Assuntos:	Stratifin Acute exacerbations Interstitial lung disease Biomarker
Acesso em linha:	https://doi.org/10.1186/s12890-024-03184-6
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!